Technology Transfer Office | University of Colorado

U.S. Patents Awarded to CU

Technology Transfer Office of University of Colorado
Browse by Category
Life Science
Biomaterials
Diagnostic
Drug Delivery and Formulation
Medical Devices
Research Tool
Therapeutic
Physical Science
Chemicals and Materials
Copyrighted and Educational Material
Electronics
Energy
Mechanical Device
Micro and Nanotechnology
Optics
Process
Software
Test and Measurement
Latest Issued Patents
All U.S. Issued Patents
Issued Patents - Therapeutic-Drug Target (Total: 17)
Patent Title Patent No. Date Issued Available?
Modulating the Alternative Complement Pathway 8,937,046 01/20/2015 No
Inhibition of the Alternative Complement Pathway for Treatment of Traumatic Brain Injury, Spinal Cord Injury and Related Conditions 8,911,733 12/16/2014 No
Methods of Using AMPD2 Inhibitors for the Treatment of Fatty Liver, Obesity and Diabetes 8,697,628 04/15/2014 Yes
Targeting Complement Factor H For Treatment of Diseases 8,569,225 10/29/2013 No
Complement Receptor 2 Targeted Complement Modulators 8,007,804 09/24/2013 No
Complement Receptor 2 Targeted Complement Modulators 8,540,997 09/24/2013 No
Bacterial Replication Systems and Methods 8,431,376 04/30/2013 Yes
Systems and Methods for Treating Human Inflammatory and Proliferative Diseases With a Combination of Compounds, Or a Bifunctional Compound That Provides Fatty Acid Metabolism and Glycolysis Inhibition 8,329,753 12/11/2012 No
Compositions of UCP Inhibitors, FAS Antibody, A Fatty Acid Metabolism Inhibitor and/or A Glucose Metabolism Inhibitor 8,293,240 10/23/2012 No
Antibodies That Bind Urokinase-Type Plasminogen Activator and Epitopes Therefor 8,119,128 02/21/2012 Yes
Methods and Compositions For the Diagnosis and Treatment of Cyclin A-1 Associated Conditions 8,076,304 12/13/2011 Yes
Systems And Methods For Treating Human Inflammatory And Proliferative Diseases And Wounds, With Fatty Acid Metabolism Inhibitors And/Or Glycolytic Inhibitors 8,071,645 12/06/2011 No
Targeting Complement Factor H For Treatment of Diseases 7,759,304 07/20/2010 No
Compositions of UCP Inhibitors, Fas Antibody, a Fatty Acid Metabolism Inhibitor and/or a Glucose Metabolism Inhibitor 7,510,710 03/31/2009 No
Methods for Treating Human Proliferative Diseases, With a Combination of Fatty Acid Metabolism Inhibitors and Glycolytic Inhibitors 7,445,794 11/04/2008 No
Detecting and Treating Heart Failure 5,733,728 03/31/1998 Yes
Screening for Mutations by Expressing CDNA Segments 5,656,425 08/12/1997 Yes
(For more issued patents, please click the categories to the left.) Export to Excel